Anthem Biosciences Limited — Important, 30-06-2026: Updates
30-06-2026 | 10:17 pm
30-06-2026 | 10:17 pm
Anthem Biosciences released its voluntary FY26 BRSR, highlighting significant R&D (14%) and Capex (51%) for sustainability and technology. The CRDMO business exports 85% of revenue. The company achieved zero safety incidents and improved GHG intensity. Supply chain sourcing from India notably increased to 85%.
No comments yet. Be the first to comment!
